Prostatic Neoplasms (Prostate Cancer) Summary

Networked: 51887 relevant articles (3001 outcomes, 10603 trials/studies) for this Disease

Key Drugs and Agents for Prostatic Neoplasms

1. Hormones : 340 outcomes 938 studies in 4759 results : IBA
   
2. docetaxel (Taxotere) : 228 outcomes 459 studies in 1363 results : FDA 3
   
3. Prostate-Specific Antigen (Semenogelase) : 205 outcomes 849 studies in 6612 results : IBA
   
4. Gonadotropin-Releasing Hormone (GnRH) : 92 outcomes 190 studies in 1126 results : FDA 2
   
5. Androgen Receptors (Androgen Receptor) : 58 outcomes 235 studies in 2769 results : IBA
   
6. Biological Markers (Surrogate Marker) : 56 outcomes 210 studies in 1408 results : IBA
   
7. Testosterone (Sustanon) : 51 outcomes 167 studies in 1152 results : FDA 13
   
8. zoledronic acid (zoledronate) : 51 outcomes 90 studies in 326 results : FDA 13
   
9. abiraterone : 48 outcomes 76 studies in 387 results : IBA
   
10. Estramustine : 45 outcomes 155 studies in 429 results : FDA 1
    

Diseases Related to Prostatic Neoplasms

1. Neoplasms (Cancer)
2. Neoplasm Metastasis (Metastasis)
3. Pain (Aches)
4. Breast Neoplasms (Breast Cancer)
5. Prostatic Hyperplasia (Benign Prostatic Hyperplasia)

Key Therapies for Prostatic Neoplasms

1. Castration : 337 outcomes 704 studies in 3436 results
   
2. Prostatectomy (Retropubic Prostatectomy) : 272 outcomes 938 studies in 6630 results
   
3. Radiotherapy : 218 outcomes 627 studies in 3579 results
   
4. Drug Therapy (Chemotherapy) : 184 outcomes 355 studies in 1723 results
   
5. Brachytherapy : 102 outcomes 187 studies in 1722 results